Back to Search
SANDEEP PONNIAH, M.D
M.D
Gastroenterology Physician
NPI: 1437599321IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
ME127306(FL)
Education
OTHER
Class of 2013
Research & Publications (20)
Longterm followup assessment of a HER2/neu peptide (E75) vaccine for prevention of recurrence in high-risk prostate cancer patients.
PMID 19228530·J Am Coll Surg·2009
2-rct
The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
PMID 19351776·Clin Cancer Res·2009
3-trial
Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
PMID 18726994·Cancer·2008
3-trial
Neural recognition molecules CHL1 and NB-3 regulate apical dendrite orientation in the neocortex via PTP alpha.
PMID 18046458·EMBO J·2008
7-preclinical
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
PMID 18392824·Cancer Immunol Immunother·2008
3-trial
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
PMID 18245541·Clin Cancer Res·2008
3-trial
An update on tobacco smoking among New Zealand health care workers, the current picture, 2006.
PMID 18425163·N Z Med J·2008
8-other
Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.
PMID 18612158·J Clin Oncol·2008
3-trial
Sociodemographic characteristics of New Zealand adult smokers, ex-smokers, and non-smokers: results from the 2006 Census.
PMID 18953385·N Z Med J·2008
8-other
Pattern of serum immunoreactivity against breast cancer cell lysates may predict severity of disease in breast cancer patients.
PMID 17440722·Cancer Immunol Immunother·2007
8-other
Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.
PMID 17251353·Proc Natl Acad Sci U S A·2007
7-preclinical
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine.
PMID 16783576·Cancer Immunol Immunother·2007
3-trial
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
PMID 17273752·Oncol Rep·2007
3-trial
Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
PMID 17906897·Ann Surg Oncol·2007
8-other
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
PMID 16596621·Cancer·2006
3-trial
Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.
PMID 16758122·Breast Cancer Res Treat·2006
8-other
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
PMID 16865596·Ann Surg Oncol·2006
3-trial
Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.
PMID 16546506·Surgery·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3 SHIRCLIFF WAY STE 400
JACKSONVILLE, FL 32204 - Phone
- (904) 398-7205
Quick Facts
- NPI
- 1437599321
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile